Prof. Lumír Ondřej Hanuš
Lumír Ondřej Hanuš obtained his M.S. in analytical chemistry (1972), Ph.D. in analytical chemistry (1974) and associate professor in organic chemistry (1994) from Palacký University (Olomouc, Czech Republic) and his D.Sc. in pharmaceutical chemistry (1995) from Charles University (Prague, Czech Republic). Between years 1971 and 1990 did research and taught at Medical Faculty, Palacký University (Olomouc). Period 1978–1979 spent as research associate at School of Pharmacy, University of Mississippi, USA. From 1990 up to present time (as researcher, professor chaver, and Research Fellow) with School of Pharmacy (Hebrew University, Jerusalem, Israel). Between years 1997 and 1998 was visiting associate (NIDDK, NIH, Bethesda, USA) and in 2001–2002 as research fellow at NIAAA (NIH, Bethesda, USA). At present time, he is Chief Scientist at Lumirlab (Asana Bio Group Ltd.), retired Research Fellow of Hebrew University in Jerusalem and Steering Committee member (CMCER) and Senior Fellow in the Jefferson Institute of Emerging Health Professions, Thomas Jefferson University, Philadelphia, Pennsylvania (from 2017) He was awarded with Honorary Doctorate degree – Chemiae Doctor honoris causa (2007) and Medicinae Doctor honoris causa (2011), Hanuš medal (2005), Outstanding Immigrant Scientist in Life Sciences and Medicine (2010), Addictology Award (2012), Olomouc City Award (2013), Lifetime Award Winner (2016), and Lifetime Achievement Award, Jamaica (2018).
On March 24, 1992 he was the first person to isolate from the brain first endogenous ligand for cannabinoid receptor which was named anandamide. This discovery opened the world to medicinal use of cannabis.
Major research interest: chemistry and pharmacology of natural products, particularly cannabis.